Patient participation in cancer network governance: a six-year case study.

Cancer Collaborative governance Governance functions Multiple case study design Networks Patient participation Qualitative data

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
07 Sep 2021
Historique:
received: 29 07 2020
accepted: 30 07 2021
entrez: 8 9 2021
pubmed: 9 9 2021
medline: 10 9 2021
Statut: epublish

Résumé

Patient participation in decision-making has become a hallmark of responsive healthcare systems. Cancer networks in many countries have committed to involving people living with and beyond cancer (PLC) at multiple levels. However, PLC participation in network governance remains highly variable for reasons that are poorly understood. This study aims to share lessons learned regarding mechanisms that enable PLC participation in cancer network governance. This multiple case study, using a qualitative approach in a natural setting, was conducted over six years in three local cancer networks within the larger national cancer network in Quebec (Canada), where PLC participation is prescribed by the Cancer Directorate. Data were collected from multiple sources, including individual and focus group interviews (n = 89) with policymakers, managers, clinicians and PLC involved in national and local cancer governance committees. These data were triangulated and iteratively analysed according to a framework based on functions of collaborative governance in the network context. We identify three main mechanisms that enable PLC participation in cancer network governance: (1) consistent emphasis on patient-centred care as a network objective; (2) flexibility, time and support to translate mandated PLC representation into meaningful participation; and (3) recognition of the distinct knowledge of PLC in decision-making. The shared vision of person-centred care facilitates PLC participation. The quality of participation improves through changes in how committee meetings are conducted, and through the establishment of a national committee where PLC can pool their experience, develop skills and establish a common voice on priority issues. PLC knowledge is especially valued around particular challenges such as designing integrated care trajectories and overcoming barriers to accessing care. These three mechanisms interact to enable PLC participation in governance and are activated to varying extents in each local network. This study reveals that mandating PLC representation on governance structures is a powerful context element enabling participation, but that it also delineates which governance functions are open to influence from PLC participation. While the activation of mechanisms is context dependent, the insights from this study in Quebec are transferable to cancer networks in other jurisdictions seeking to embed PLC participation in decision-making.

Sections du résumé

BACKGROUND BACKGROUND
Patient participation in decision-making has become a hallmark of responsive healthcare systems. Cancer networks in many countries have committed to involving people living with and beyond cancer (PLC) at multiple levels. However, PLC participation in network governance remains highly variable for reasons that are poorly understood. This study aims to share lessons learned regarding mechanisms that enable PLC participation in cancer network governance.
METHODS METHODS
This multiple case study, using a qualitative approach in a natural setting, was conducted over six years in three local cancer networks within the larger national cancer network in Quebec (Canada), where PLC participation is prescribed by the Cancer Directorate. Data were collected from multiple sources, including individual and focus group interviews (n = 89) with policymakers, managers, clinicians and PLC involved in national and local cancer governance committees. These data were triangulated and iteratively analysed according to a framework based on functions of collaborative governance in the network context.
RESULTS RESULTS
We identify three main mechanisms that enable PLC participation in cancer network governance: (1) consistent emphasis on patient-centred care as a network objective; (2) flexibility, time and support to translate mandated PLC representation into meaningful participation; and (3) recognition of the distinct knowledge of PLC in decision-making. The shared vision of person-centred care facilitates PLC participation. The quality of participation improves through changes in how committee meetings are conducted, and through the establishment of a national committee where PLC can pool their experience, develop skills and establish a common voice on priority issues. PLC knowledge is especially valued around particular challenges such as designing integrated care trajectories and overcoming barriers to accessing care. These three mechanisms interact to enable PLC participation in governance and are activated to varying extents in each local network.
CONCLUSIONS CONCLUSIONS
This study reveals that mandating PLC representation on governance structures is a powerful context element enabling participation, but that it also delineates which governance functions are open to influence from PLC participation. While the activation of mechanisms is context dependent, the insights from this study in Quebec are transferable to cancer networks in other jurisdictions seeking to embed PLC participation in decision-making.

Identifiants

pubmed: 34493271
doi: 10.1186/s12913-021-06834-1
pii: 10.1186/s12913-021-06834-1
pmc: PMC8423332
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

929

Subventions

Organisme : Fonds de Recherche du Québec - Santé
ID : 27193
Organisme : Fonds de Recherche du Québec - Santé
ID : 265874

Informations de copyright

© 2021. The Author(s).

Références

Health Aff (Millwood). 2010 Aug;29(8):1489-95
pubmed: 20679652
Health Policy. 2014 May;116(1):1-11
pubmed: 24485914
Int J Health Policy Manag. 2018 Oct 02;8(1):49-50
pubmed: 30709102
Healthc Q. 2015;17 Spec No:28-32
pubmed: 25562131
Aust J Rural Health. 2011 Dec;19(6):324-8
pubmed: 22098217
Implement Sci. 2011 Mar 22;6:25
pubmed: 21426573
Healthc Q. 2015;17 Spec No:48-51
pubmed: 25562135
BMC Health Serv Res. 2013 Jun 24;13:229
pubmed: 23800334
Implement Sci. 2014 Feb 20;9:24
pubmed: 24555508
Soc Sci Med. 2012 Feb;74(3):340-347
pubmed: 21501913
Soc Sci Med. 2016 Feb;150:31-9
pubmed: 26730879
BMJ Open. 2018 Aug 5;8(8):e018896
pubmed: 30082339
Curr Hematol Malig Rep. 2016 Aug;11(4):303-10
pubmed: 27262855
Patient Educ Couns. 2016 Dec;99(12):1923-1939
pubmed: 27450481
J Pediatr Psychol. 2016 Jun;41(5):493-505
pubmed: 27118271
J Support Oncol. 2012 May-Jun;10(3):107-11
pubmed: 22440532
Int J Health Policy Manag. 2016 Jul 03;6(1):49-51
pubmed: 28005542
Healthc Q. 2018 Dec;21(SP):38-44
pubmed: 30566402
AJS. 2009 Nov;115(3):657-711
pubmed: 20503740
J Oncol Pract. 2016 Nov;12(11):1012-1019
pubmed: 27650834
Health Policy. 2017 Oct;121(10):1031-1039
pubmed: 28919056
BMJ Qual Saf. 2011 Apr;20 Suppl 1:i43-6
pubmed: 21450770
Patient Educ Couns. 2020 Jan;103(1):5-14
pubmed: 31447194
Implement Sci. 2016 Mar 21;11:39
pubmed: 27000152
Lancet Oncol. 2006 Apr;7(4):336-46
pubmed: 16574549
BMC Health Serv Res. 2019 Oct 25;19(1):752
pubmed: 31653231
Health Expect. 2016 Aug;19(4):790-804
pubmed: 26072929
Implement Sci. 2018 Jul 26;13(1):98
pubmed: 30045735

Auteurs

Dominique Tremblay (D)

Centre de recherche Charles-Le Moyne - Saguenay-Lac-Saint-Jean sur les innovations en santé, Campus de Longueuil - Université de Sherbrooke, 150 Place Charles LeMoyne - Bureau 200, Québec, J4K 0A, Longueuil, Canada. dominique.tremblay2@usherbrooke.ca.

Nassera Touati (N)

École Nationale d'Administration Publique, 4750 ave Henri-Julien, 5e étage, Québec, H2T 3E5, Montréal, Canada.

Susan Usher (S)

Centre de recherche Charles-Le Moyne - Saguenay-Lac-Saint-Jean sur les innovations en santé, Campus de Longueuil - Université de Sherbrooke, 150 Place Charles LeMoyne - Bureau 200, Québec, J4K 0A, Longueuil, Canada.
École Nationale d'Administration Publique, 4750 ave Henri-Julien, 5e étage, Québec, H2T 3E5, Montréal, Canada.

Karine Bilodeau (K)

Faculty of Nursing, Université de Montréal, Pavillon Marguerite-d'Youville, local 7101, 2375 chemin de la Côte-Ste-Catherine, Québec, H3T 1A8, Montréal, Canada.

Marie-Pascale Pomey (MP)

School of Public Health, Université de Montréal, 7101 ave du Parc, 3e étage, bureau 3014-8, Québec, H3N 1X9, Montréal, Canada.

Lise Lévesque (L)

Centre de recherche Charles-Le Moyne - Saguenay-Lac-Saint-Jean sur les innovations en santé, Campus de Longueuil - Université de Sherbrooke, 150 Place Charles LeMoyne - Bureau 200, Québec, J4K 0A, Longueuil, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH